Skip to content
A1793Assembly2021-2022 Session

Cover Bone Marrow Test Costs

Official title

“Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing for use in tissue typing for bone marrow testing”

Sponsor J. Gary PretlowAD-89Affects Finance
Status
In Assembly Committee
Insurance
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires health insurance policies in New York to cover human leukocyte antigen (HLA) testing for bone marrow typing.

Why it matters

  1. Improves access to bone marrow transplants. By requiring insurance coverage for HLA testing, the bill removes a cost barrier for patients who need to determine compatibility for bone marrow donation, potentially increasing the pool of eligible donors and recipients.

  2. Supports early diagnosis and treatment. Coverage for HLA testing allows for quicker and more equitable identification of suitable bone marrow donors, which can be critical for treating leukemia, lymphoma, and other life-threatening blood disorders.

  3. Reduces out-of-pocket costs and financial stress. Mandating coverage means patients are less likely to face significant personal expenses for necessary genetic testing, making advanced medical care more financially accessible to a broader segment of the population.

  4. Standardizes coverage across most insurance plans. The bill applies to individual, group, and blanket health insurance policies issued in New York, except for multi-state plans or those under certain collective bargaining agreements, thus closing coverage gaps for most residents.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Cover Bone Marrow Test Costs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
J. Gary Pretlow

Assembly Member · Assembly District 89

Chair, Ways and Means

No co-sponsors yet.

History

  1. Referred to insurance
  2. Referred to insurance

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1793

2021-2022 Regular Sessions

IN ASSEMBLY

January 11, 2021

Introduced by M. of A. PRETLOW -- read once and referred to the Committee on Insurance

AN ACT to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:

(36) Every policy which provides hospital, surgical, or medical care coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing.

§ 2. Subsection (1) of section 3221 of the insurance law is amended by adding a new paragraph 21 to read as follows:

(21) Every group or blanket policy delivered or issued for delivery in this state which provides hospital, surgical, or medical care coverage shall provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing, except that this provision shall not apply to a policy which covers persons employed in more than one state or the benefit structure of which was the subject of collective bargaining affecting persons who are employed in more than one state.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:

(ss) A medical expense indemnity corporation, a hospital service corporation or a health service corporation which provides coverage for hospital, surgical, or medical care shall provide coverage for human

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00258-01-1

A. 1793 2

leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing, except that this provision shall not apply to a contract which covers persons employed in more than one state or the benefit structure of which was the subject of collective bargaining affecting persons who are employed in more than one state.

§ 4. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered, or amended on or after such effective date. Effective immediately any rules or regulations necessary for the implementation of this act on its effective date shall be promulgated, and any other measures necessary for the implementation of this act on its effective date shall be taken, on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.